128 related articles for article (PubMed ID: 15670924)
1. Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques.
Bhattacharya P; Leonard JT; Roy K
Bioorg Med Chem; 2005 Feb; 13(4):1159-65. PubMed ID: 15670924
[TBL] [Abstract][Full Text] [Related]
2. QSAR of adenosine A3 receptor antagonist 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives using chemometric tools.
Bhattacharya P; Roy K
Bioorg Med Chem Lett; 2005 Aug; 15(16):3737-43. PubMed ID: 15993066
[TBL] [Abstract][Full Text] [Related]
3. QSAR of adenosine receptor antagonists. Part 3: Exploring physicochemical requirements for selective binding of 1,2,4-triazolo[5,1-i]purine derivatives with human adenosine A3 receptor subtype.
Roy K; Leonard JT; Sengupta C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3705-9. PubMed ID: 15203147
[TBL] [Abstract][Full Text] [Related]
4. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
Roy K; Leonard JT
Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
[TBL] [Abstract][Full Text] [Related]
5. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
Thomas Leonard J; Roy K
Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
[TBL] [Abstract][Full Text] [Related]
6. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
Bhattacharya P; Leonard JT; Roy K
J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
[TBL] [Abstract][Full Text] [Related]
7. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
Roy K; Leonard JT
J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
[TBL] [Abstract][Full Text] [Related]
8. QSAR study on thiazole and thiadiazole analogues as antagonists for the adenosine A1 and A3 receptors.
Borghini A; Pietra D; Domenichelli P; Bianucci AM
Bioorg Med Chem; 2005 Sep; 13(18):5330-7. PubMed ID: 15990318
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling of globulin binding affinity of corticosteroids using AM1 calculations.
De K; Sengupta C; Roy K
Bioorg Med Chem; 2004 Jun; 12(12):3323-32. PubMed ID: 15158800
[TBL] [Abstract][Full Text] [Related]
10. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
11. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
12. QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.
Pran Kishore D; Balakumar C; Raghuram Rao A; Roy PP; Roy K
Bioorg Med Chem Lett; 2011 Jan; 21(2):818-23. PubMed ID: 21163647
[TBL] [Abstract][Full Text] [Related]
13. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters.
Chakraborty S; Sengupta C; Roy K
Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586
[TBL] [Abstract][Full Text] [Related]
14. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
15. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
Sabet R; Fassihi A; Moeinifard B
J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
[TBL] [Abstract][Full Text] [Related]
16. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters.
Mukherjee S; Saha A; Roy K
Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893
[TBL] [Abstract][Full Text] [Related]
17. QSAR modelling of pancreatic beta-cell KATP channel openers R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2H-1-benzopyrans using MLR-FA techniques.
Alam SM; Samanta S; Halder AK; Basu S; Jha T
Eur J Med Chem; 2009 Jan; 44(1):359-64. PubMed ID: 18420311
[TBL] [Abstract][Full Text] [Related]
18. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
Mitra I; Roy K; Saha A
J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
[TBL] [Abstract][Full Text] [Related]
19. 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
Biagi G; Bianucci AM; Coi A; Costa B; Fabbrini L; Giorgi I; Livi O; Micco I; Pacchini F; Santini E; Leonardi M; Nofal FA; Salerni OL; Scartoni V
Bioorg Med Chem; 2005 Aug; 13(15):4679-93. PubMed ID: 15908217
[TBL] [Abstract][Full Text] [Related]
20. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
Leonard JT; Roy K
Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]